Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.3
16.65%
40%
—
21.56%
60%
—
5 Years
Score4.3
Net Growth16.65%
Net Trend40%
Net Income Consistency—
Rev Growth21.56%
Rev Trend60%
Revenue Consistency—
Aclaris Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 6M to $ 7M and net income went from -$ 51M to -$ 64M. Revenue increased in 3 of those 5 years; net income in 2.
Aclaris Therapeutics Inc currently holds a 5-year HDB Score of 4.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 5.84 | — |
1 Year2025-08-12 | $ 1.64 | 256.10% |
5 Years2021-08-12 | $ 15.11 | -61.35% |
10 Years2016-08-12 | $ 19.27 | -69.69% |
All Time2015-10-07 | $ 11.05 | -47.15% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-10-07 |
|---|---|---|---|---|---|
| Price | $ 5.84 | $ 1.64 | $ 15.11 | $ 19.27 | $ 11.05 |
| Return | — | 256.10% | -61.35% | -69.69% | -47.15% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 8M | -$ 75M | $ 91M |
| 2025 | $ 7M | -$ 64M | $ 90M |
| 2024 | $ 18M | -$ 132M | $ 113M |
| 2023 | $ 31M | -$ 88M | $ 119M |
| 2022 | $ 29M | -$ 86M | $ 217M |
| 2021 | $ 6M | -$ 90M | $ 191M |
| 2020 | $ 6M | -$ 51M | $ 54M |
| 2019 | $ 4M | -$ 161M | $ 75M |
| 2018 | $ 10M | -$ 132M | $ 167M |
| 2017 | $ 1M | -$ 68M | $ 208M |
| 2016 | $ 0.00 | -$ 48M | $ 174M |
| IPO2015 | $ 0.00 | -$ 20M | $ 92M |
Explore beyond ACRS
You're looking at Aclaris Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- AMN Healthcare Services IncAMN· revenue grew in 40% of years
- Seres Therapeutics IncMCRB· revenue grew in 60% of years
- Simulations Plus IncSLP· revenue grew in 100% of years
- Creative Medical Technology Holdings IncCELZ· revenue grew in 40% of years
- Lexicon Pharmaceuticals IncLXRX· revenue grew in 60% of years
